By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site.
Industry: Medical Devices
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.
Institution %: 101.861
YTD Institution change: -254452
InsidersInsiders %: 0.341
Insiders Purchases YTD:
Insiders Sales YTD: 45540
Insiders Net YTD: -45540
Analyst RatingsTarget Price: 257.94
Overall Rating: 4.4546
Strong Buys (5): 13
Buys (4): 6
Holds (3): 3
Sells (2): 0
Strong Sells (1): 0
52 Week Hi: 243.98
52 Week Low: 125.82
Beta: 1.212
50 Day MA: 209.6416
200 Day MA: 192.5692
Earnings / Revenue TrendsQtr Earnings Growth YOY: 5.639
Qtr Revenue Growth YOY: 0.232
Forward PE:
Trailing PE: